TGFA and colorectal cancer: Similar to TGFα, there were consistent reports that found no significant correlation between HB-EGF mRNA expression and clinical outcome parameters in colorectal cancer patients treated with cetuximab (Baker et al. 2011; Cushman et al. 2015; Khambata-Ford et al. 2007).